Rykel van Bruggen

956 total citations
16 papers, 302 citations indexed

About

Rykel van Bruggen is a scholar working on Radiology, Nuclear Medicine and Imaging, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rykel van Bruggen has authored 16 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rykel van Bruggen's work include Cardiac Imaging and Diagnostics (5 papers), Acute Myocardial Infarction Research (4 papers) and Clinical practice guidelines implementation (3 papers). Rykel van Bruggen is often cited by papers focused on Cardiac Imaging and Diagnostics (5 papers), Acute Myocardial Infarction Research (4 papers) and Clinical practice guidelines implementation (3 papers). Rykel van Bruggen collaborates with scholars based in Netherlands and United States. Rykel van Bruggen's co-authors include Ronald P. Stolk, Olaf H. Klungel, K. J. Gorter, Kees Gorter, Guy E.H.M. Rutten, G. E. H. M. Rutten, G.J. Hiddink, Edith J. M. Feskens, Annemien Haveman‐Nies and Richard L. Braam and has published in prestigious journals such as European Heart Journal, BMJ Open and European Journal of Clinical Investigation.

In The Last Decade

Rykel van Bruggen

15 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rykel van Bruggen Netherlands 8 120 66 58 57 52 16 302
Javier García Alegría Spain 12 114 0.9× 46 0.7× 96 1.7× 42 0.7× 25 0.5× 38 364
U Reitberger Germany 8 133 1.1× 43 0.7× 21 0.4× 40 0.7× 41 0.8× 15 326
Jeanene Fogli United States 8 118 1.0× 57 0.9× 60 1.0× 6 0.1× 30 0.6× 12 390
Antonio Maiques Spain 10 96 0.8× 42 0.6× 206 3.6× 16 0.3× 55 1.1× 26 296
Samira Moughrabi United States 6 44 0.4× 59 0.9× 301 5.2× 37 0.6× 55 1.1× 12 470
Khalid A. Alqurashi Saudi Arabia 2 204 1.7× 32 0.5× 24 0.4× 23 0.4× 49 0.9× 7 383
Omar Hamoui Lebanon 9 43 0.4× 17 0.3× 168 2.9× 59 1.0× 33 0.6× 20 269
Elvis A. Akwo United States 11 42 0.3× 50 0.8× 150 2.6× 11 0.2× 38 0.7× 26 347
Hanna Blackledge United Kingdom 6 42 0.3× 26 0.4× 196 3.4× 44 0.8× 11 0.2× 9 294
Pablo Lamelas Canada 9 27 0.2× 53 0.8× 291 5.0× 43 0.8× 55 1.1× 35 404

Countries citing papers authored by Rykel van Bruggen

Since Specialization
Citations

This map shows the geographic impact of Rykel van Bruggen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rykel van Bruggen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rykel van Bruggen more than expected).

Fields of papers citing papers by Rykel van Bruggen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rykel van Bruggen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rykel van Bruggen. The network helps show where Rykel van Bruggen may publish in the future.

Co-authorship network of co-authors of Rykel van Bruggen

This figure shows the co-authorship network connecting the top 25 collaborators of Rykel van Bruggen. A scholar is included among the top collaborators of Rykel van Bruggen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rykel van Bruggen. Rykel van Bruggen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Harst, Pim van der, Rykel van Bruggen, Jan W. Gratama, et al.. (2022). The Diagnostic and Prognostic Value of Coronary Calcium Scoring in Stable Chest Pain Patients: A Narrative Review. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 194(3). 257–265. 7 indexed citations
2.
3.
Aalst, Carlijn M. van der, Marleen Vonder, Jan W. Gratama, et al.. (2020). Screening for cardiovascular disease risk using traditional risk factor assessment or coronary artery calcium scoring: the ROBINSCA trial. European Heart Journal - Cardiovascular Imaging. 21(11). 1216–1224. 50 indexed citations
4.
Aalst, Carlijn van der, Marleen Vonder, Henk J Adriaansen, et al.. (2020). Risk results from screening for a high cardiovascular disease risk by means of traditional risk factor measurement or coronary artery calcium scoring in the ROBINSCA trial. European Heart Journal. 41(Supplement_2). 2 indexed citations
5.
Aalst, Carlijn M. van der, Marleen Vonder, Henk J Adriaansen, et al.. (2019). Risk or Benefit in Screening for Cardiovascular Disease (ROBINSCA): The Rationale and Study Design of a Population-Based Randomized-Controlled Screening Trial for Cardiovascular Disease. Data Archiving and Networked Services (DANS). 9(1). 1–8. 11 indexed citations
6.
Haveman‐Nies, Annemien, et al.. (2017). Effect and maintenance of the SLIMMER diabetes prevention lifestyle intervention in Dutch primary healthcare: a randomised controlled trial. Nutrition and Diabetes. 7(5). e268–e268. 36 indexed citations
7.
Haveman‐Nies, Annemien, et al.. (2017). SLIMMER diabetes voorkomen in de eerste lijn. Huisarts en Wetenschap. 60(4). 160–163.
8.
Haveman‐Nies, Annemien, et al.. (2012). Translating the SLIM diabetes prevention intervention into SLIMMER: implications for the Dutch primary health care. Family Practice. 29(suppl 1). i145–i152. 7 indexed citations
9.
Beek, Eline M. van der, Rykel van Bruggen, Karin Schornagel, et al.. (2010). SIRP alpha controls phagocyte NADPH oxidase function by limiting the expression of gp91(phox). European Journal of Clinical Investigation. 40. 34–34. 1 indexed citations
10.
Bruggen, Rykel van, et al.. (2009). Clinical inertia in general practice: widespread and related to the outcome of diabetes care. Family Practice. 26(6). 428–436. 71 indexed citations
11.
Bruggen, Rykel van, et al.. (2009). Refill adherence and polypharmacy among patients with type 2 diabetes in general practice. Pharmacoepidemiology and Drug Safety. 18(11). 983–991. 51 indexed citations
12.
Bruggen, Rykel van, et al.. (2008). Implementation of locally adapted guidelines on type 2 diabetes. Family Practice. 25(6). 430–437. 41 indexed citations
13.
Bruggen, Rykel van, et al.. (2008). Overall quality of diabetes care in a defined geographic region: different sides of the same story. British Journal of General Practice. 58(550). 339–345. 19 indexed citations
14.
Verhoeven, Aswin, et al.. (2007). EMR3: a new marker for fully differentiated neutrophils. European Journal of Clinical Investigation. 37. 15–15. 1 indexed citations
15.
Bruggen, Rykel van, K. J. Gorter, Ronald P. Stolk, Olaf H. Klungel, & G. E. H. M. Rutten. (2007). Diabetes care and clinical inertia in general practice: Predicting factors and outcome of care. Primary care diabetes. 1(4). 228–229. 1 indexed citations
16.
Bruggen, Rykel van. (2004). Built for the kill. Studies on the neutrophil NADPH oxidase. UvA-DARE (University of Amsterdam). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Javier García Alegría Breakdown of academic impact, for papers by U Reitberger Breakdown of academic impact, for papers by Jeanene Fogli Breakdown of academic impact, for papers by Antonio Maiques Breakdown of academic impact, for papers by Samira Moughrabi Breakdown of academic impact, for papers by Khalid A. Alqurashi Breakdown of academic impact, for papers by Omar Hamoui Breakdown of academic impact, for papers by Elvis A. Akwo Breakdown of academic impact, for papers by Hanna Blackledge Breakdown of academic impact, for papers by Pablo Lamelas
Rankless by CCL
2026